Ryutaro Arita

Effect of ninjin'yoeito, a <scp>K</scp>ampo (traditional <scp>J</scp>apanese) medicine, on cognitive impairment and depression in patients with <scp>A</scp>lzheimer's disease: 2 years of observation

Chiaki Kudoh, Ryutaro Arita, Mitsuru Honda et al. · Psychogeriatrics · 2015 · 67 citations

Kakkonto, shosaikoto, <scp><i>Platycodon grandiflorum</i></scp> root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to <scp>COVID</scp>‐19

Ryutaro Arita, Rie Ono, Natsumi Saito et al. · Traditional & Kampo Medicine · 2020 · 23 citations · Full text

Immunology, Antiviral Drug, Covid-19 +21

Characteristics and course of patients treated with Kampo Medicine in the Department of General Medicine

Shin Takayama, Tetsuya Akaishi, Hiroyuki Nozaki et al. · Journal of General and Family Medicine · 2020 · 21 citations · Full text

Prescription of Kampo Formulations for Pre-natal and Post-partum Women in Japan: Data From an Administrative Health Database

Satoko Suzuki, Taku Obara, Tomofumi Ishikawa et al. · Frontiers in Nutrition · 2021 · 18 citations · Full text

Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients

Shin Takayama, Takao Namiki, Ryutaro Arita et al. · Frontiers in Pharmacology · 2022 · 18 citations · Full text

Disease Management, Control Group, Long Covid +14